Predictive Oncology appoints Dr Bernard Harris Jr to Business Advisory BoardProactive Investors • 06/20/23
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory BoardGlobeNewsWire • 06/20/23
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International ConventionGlobeNewsWire • 05/23/23
Predictive Oncology forges key partnerships to drive oncology drug development in 1QProactive Investors • 05/16/23
Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 05/15/23
Predictive Oncology appoints healthcare commercial and business development veteran to its boardProactive Investors • 05/03/23
Predictive Oncology appoints translational research leader Christoph Reinhard to scientific advisory boardProactive Investors • 04/04/23
Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory BoardGlobeNewsWire • 04/04/23
Predictive Oncology partners with Integra Therapeutics to advance gene therapyProactive Investors • 03/30/23
Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene TherapyGlobeNewsWire • 03/30/23
Predictive Oncology hails potential of PEDAL drug discovery platform as it reports 2022 resultsProactive Investors • 03/22/23
Predictive Oncology Reports Year End 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 03/21/23
Predictive Oncology and Cancer Research Horizons partner up to pursue development of cancer drugsProactive Investors • 03/17/23
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugsGlobeNewsWire • 03/17/23
Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common StockGlobeNewsWire • 03/16/23